Zhang Yunfeng, Zhou Qixing, Zou Ying, Song Xiaolian, Xie Shuanshuan, Tan Min, Zhang Guoliang, Wang Changhui
Department of Respiratory Medicine, Shanghai Liqun Hospital, Putuo District, Shanghai, 200333, China.
Department of Respiratory Medicine, Shanghai Tenth People's Hospital, Tongji University, Shanghai, 200072, China.
J Thromb Thrombolysis. 2016 May;41(4):619-27. doi: 10.1007/s11239-015-1275-6.
D-dimer levels are increased in patients with acute pulmonary embolism (PE). However, D-dimer levels are also increased in patients with community-acquired pneumonia (CAP). The aim of this prospective cohort study was to examine the incidence and clinical features of patients preliminarily diagnosed with CAP and with increased D-dimer levels, and who finally were diagnosed with PE. Patients diagnosed with CAP and hospitalized in the Respiratory Department of the Tenth People's Hospital Affiliated to Tongji University between May 2011 and May 2013 were enrolled. D-dimer levels were measured routinely after admission. For patients with increased D-dimer levels, those suspected with PE underwent computed tomography pulmonary angiography (CTPA). A total of 2387 patients with CAP was included: 724 (30.3 %) had increased D-dimer levels (median of 0.91 mg/L). CTPA was performed for 139 of the 724 patients (median D-dimer levels of 1.99 mg/L). Among the 139 patients, 80 were diagnosed with PE, and 59 without PE; D-dimer levels were 2.83 and 1.41 mg/L, respectively (p < 0.05). Multivariate analysis showed that age, coronary heart disease, chronic obstructive pulmonary disease (COPD), lower limb varicosity, chest pain, shortness of breath, hemoptysis, fever, and increased levels of troponin I were independent risk factors for PE. Presentation of PE and CAP are similar. Nevertheless, these results indicated that for hospitalized patients with CAP and elevated D-dimer levels, PE should be considered for those >60 years; with CHD, COPD, or lower limb varicosity; with chest pain, shortness of breath, hemoptysis, increased troponin I, or low fever.
急性肺栓塞(PE)患者的D-二聚体水平会升高。然而,社区获得性肺炎(CAP)患者的D-二聚体水平也会升高。这项前瞻性队列研究的目的是检查初步诊断为CAP且D-二聚体水平升高、最终被诊断为PE的患者的发病率和临床特征。纳入了2011年5月至2013年5月期间在同济大学附属第十人民医院呼吸科住院的CAP患者。入院后常规测量D-二聚体水平。对于D-二聚体水平升高的患者,怀疑有PE的患者接受计算机断层扫描肺动脉造影(CTPA)。共纳入2387例CAP患者:724例(30.3%)D-二聚体水平升高(中位数为0.91mg/L)。724例患者中的139例(D-二聚体水平中位数为1.99mg/L)进行了CTPA。在这139例患者中,80例被诊断为PE,59例未被诊断为PE;D-二聚体水平分别为2.83和1.41mg/L(p<0.05)。多因素分析表明,年龄、冠心病、慢性阻塞性肺疾病(COPD)、下肢静脉曲张、胸痛、气短、咯血、发热和肌钙蛋白I水平升高是PE的独立危险因素。PE和CAP的表现相似。然而,这些结果表明,对于住院的CAP患者且D-二聚体水平升高,年龄>60岁、患有冠心病、COPD或下肢静脉曲张、有胸痛、气短、咯血、肌钙蛋白I升高或低热的患者应考虑PE。